Rituximab/bendamustine and rituximab/cytarabine induction therapy for transplant-eligible mantle cell lymphomaReid W. Merryman, Eric D. Jacobsen, Jennifer L. Crombie et al.|Blood Advances|2020Cited by 58
Interim Positron Emission Tomography During Frontline Chemoimmunotherapy for Follicular LymphomaReid W. Merryman, Heather A. Jacene, Laure Michaud et al.|HemaSphere|2023Cited by 11
Rituximab/Bendamustine and Rituximab/Cytarabine (RB/RC) Induction Chemotherapy for Transplant-Eligible Patients with Mantle Cell Lymphoma: A Pooled Analysis of Two Phase 2 Clinical Trials and Off-Trial ExperienceReid W. Merryman, Eric D. Jacobsen, Brad S. Kahl et al.|Blood|2018Cited by 7
Interim Positron Emission Tomography (iPET) Assessed Using Deauville Score for Patients with Follicular Lymphoma Receiving First-Line ChemoimmunotherapyReid W. Merryman, Heather A. Jacene, Gabriela Spilberg et al.|Blood|2020Cited by 1
A prospective study of minimal residual disease in patients with diffuse large B-cell lymphoma using an Ig-NGS assayMatthew Chase, Jennifer L. Crombie, Reid W. Merryman et al.|Leukemia & lymphoma/Leukemia and lymphoma|2020Cited by 1